Marshall Wace, LLP Treace Medical Concepts, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 135,877 shares of TMCI stock, worth $885,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135,877
Previous 38,148
256.18%
Holding current value
$885,918
Previous $320,000
149.38%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TMCI
# of Institutions
123Shares Held
40MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY6.26MShares$40.8 Million0.64% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$26.5 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.1MShares$20.2 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$17.8 Million0.0% of portfolio
-
Cibc Private Wealth Group, LLC2.29MShares$15 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $361M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...